Edition: United Kingdom United Kingdom Select Region
Email: Passwd: or sign up free
One News Page
One News Page United Kingdom > Markets > Boston Scientific Launches New Implantable Defibrillation Lead in Europe and Asia
Open news article

Boston Scientific Launches New Implantable Defibrillation Lead in Europe and Asia

Benzinga.com
Monday, 24 September 2012

Boston Scientific Corporation (NYSE: BSX) has received regulatory approval to market the RELIANCE® 4-FRONT™ lead, its next generation implantable defibrillation lead now available in Europe and Asia.
0
shares
Share on FacebookShare on Twitter Comment
 

You Might Like


Other recent news in Markets

Apple Earnings Preview: Will iPhone SALES Disappoint Investors?3 Reasons Why Tesla Motors Inc.'s Sales in China Will Accelerate When It Starts MANUFACTURING In-Cou
Markets await APPLE and Facebook earnings amid tech bubble warningThe AMAZON Tax Problem: What Collecting Sales Tax Costs the Online Retail Giant
New HOME SALES Suggest Prolonged Housing WeaknessPROCTER & GAMBLE Q3 Adj. Profit Tops View, But Sales Miss; Backs 2014 Outlook
GOOGLE's Next Big Bet: Beat Apple at Its Own GameFACEBOOK Earnings Preview: Reassurance Required After M&A Heavy Quarter
Mid-Morning Market Update: Markets Fall; BOEING Profit Tops Street ViewECB Ready if Inflation Misses TARGET

Twitter


Comments

comments powered by Disqus

Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2014 One News Page Ltd. All Rights Reserved.  |  About us  |  Press Room  |  Terms & Conditions  |  Privacy Policy  |  Content Accreditation
One News Page - Top Headlines RSS Feed RSS  |  News for my Website  |  Free news search widget  |  Advertise  |  Help  |  Contact us  |  DMCA / Content Removal
How are we doing? Send us your feedback  |  One News Page on Facebook LIKE us on Facebook  One News Page on Twitter FOLLOW us on Twitter  One News Page on Google+ FIND us on Google+



Bullet: One News Page official news app for iPhone Bullet: Our news app for iPhone
-